
This episode features Martine Rothblatt, CEO of United Therapeutics, discussing her journey as a transgender woman, entrepreneur, and advocate for digital immortality.
Martine shares her background, including founding United Therapeutics to save her daughter from pulmonary arterial hypertension. She highlights her leadership style, emphasizing personal engagement with employees and the importance of questioning decisions.
The conversation shifts to the development of manufactured organs and the future of lung transplantation. Martine explains the potential for creating a supply of organs and the timeline for this technology.
Martine also discusses her book, "Virtually Human," which addresses digital immortality and the implications of AI and big data in creating digital doppelgangers. She reflects on societal acceptance of new technologies and their impact on human relationships.
Finally, Martine touches on her philosophy of transhumanism and the importance of freedom of movement, drawing from her Jewish heritage and American values.
Martine Rothblatt discusses her journey, digital immortality, and the future of organ manufacturing in this episode.

This episode stands out for the following:
I just wanted to save my daughter.The Promise and Peril of Digital Mortality
Digital immortality is what you have when you combine big data with AI.The Promise and Peril of Digital Mortality
Pain is pain and pain is bad.The Promise and Peril of Digital Mortality
I believe that it will democratize faster than any technology in history.The Promise and Peril of Digital Mortality
Learning is important because people can take away everything that you have.The Promise and Peril of Digital Mortality